Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids may help treat various skin conditions.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Melatonin affects skin and hair color and protects skin cells, with potential benefits for hair growth and skin health.

The secretome from mesenchymal stem cells shows promise for treating skin conditions and improving skin and hair health, but more research is needed.

Targeting Vδ1+T-cells may help treat alopecia areata.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Topical immunotherapy is the best treatment for severe alopecia areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Scientists found the best time to transplant human stem cells for hair growth is between days 16-18 when they have the right markers and growth potential.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.